Messenger ribonucleic acid levels of steroid 5 alpha-reductase 2 in human prostate predict the enzyme activity

Citation
Tg. Soderstrom et al., Messenger ribonucleic acid levels of steroid 5 alpha-reductase 2 in human prostate predict the enzyme activity, J CLIN END, 86(2), 2001, pp. 855-858
Citations number
27
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
86
Issue
2
Year of publication
2001
Pages
855 - 858
Database
ISI
SICI code
0021-972X(200102)86:2<855:MRALOS>2.0.ZU;2-2
Abstract
Testosterone is converted to dihydrotestosterone by 5 alpha -reductase2 in the prostate. Dihydrotestosterone controls cell division, and interindividu al differences in prostatic 5 alpha -reductase 2 expression and activity ma y be a determinant of the risk of developing prostate cancer. However, litt le is known about interindividual differences in intraprostatic hormonal ac tivity in vivo. To determine whether 5 alpha -reductase-specific messenger RNA (mRNA) is predictive of 5 alpha -reductase activity in prostatic tissue , we analyzed 30 prostatic tissue specimens from 15 Caucasian patients, 47- 82 yr old. The mRNA was measured by RT-PCR. Five specimens consisted of can cer, whereas the remaining 25 were derived from benign prostate hyperplasia (BPH). We found a strong association between enzyme activity at pH 5.5 and the 5 alpha -reductase 2-specific mRNA expression when expressed on the ba sis of beta -actin [Spearman's rank-correlation coefficient (r(s)) = 0.81; 95% confidence interval, 0.64-0.91; P < 0.0001]. The expression of 5<alpha> -reductase 2-specific mRNA in the cancer specimens was significantly lower than in the BPH tissue (P = 0.03). There was no difference in the expressio n of 5 alpha -reductase 1-specific mRNA in the cancer specimens, compared w ith BPH (P = 0.56). The strong association between 5 alpha -reductase activ ity at pH 5.5 and the 5 alpha -reductase 2-specific mRNA expression makes i t possible to predict prostatic Sa-reductase activity using core needle bio psies.